Ftse Mib
37.735,12
0,41%
DAX
22.068,99
0,16%
S&P 500
6.068,50
0,03%
NASDAQ
19.643,86
-0,36%
Bitcoin
96.242,00
0,51%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ XORTX Therapeutics Inc (XRTX) XORTX Therapeutics Inc (XRTX) Notizie

XORTX Therapeutics Inc

XRTX
0,95
0,00 (0,00%)
12 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/1/202513:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202513:00GLOBEXORTX to Present at Microcap Conference
22/1/202519:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/1/202516:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202523:00GLOBEXORTX Announces Change of Auditor
06/1/202523:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202513:00GLOBEXORTX Adds Late Stage Gout Program to Pipeline
19/12/202415:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202413:00GLOBEXORTX Strengthens Executive Team
13/12/202423:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/12/202416:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202415:17GLOBEXORTX Announces Presentation at the Rare and Genetic Disease..
26/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202418:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/11/202418:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/11/202423:01EDGAR2Form F-1 - Registration statement for certain foreign..
15/11/202417:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202414:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202413:00GLOBEXORTX Sponsored Study Presented at the American Society of..
18/10/202423:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202423:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202422:00GLOBEXORTX Announces Closing of US$1.5 Million Registered Direct..
18/10/202412:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202412:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/10/202416:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202414:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/10/202414:00GLOBEXORTX Announces Pricing of US$1.5 Million Registered Direct..
09/10/202416:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/10/202411:00GLOBEXORTX Initiates Precision Medicine Program
24/9/202412:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/9/202412:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/9/202412:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/9/202412:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/9/202412:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/9/202422:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202413:00GLOBEXORTX Announces Results of Annual and Special Meeting of..
12/9/202423:30GLOBEXORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
06/9/202423:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202423:30GLOBEXORTX Reminds Shareholders of Voting Deadline for Upcoming..
03/9/202418:30GLOBEIndependent Proxy Advisory Firm ISS Recommends XORTX..
29/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202413:00GLOBEXORTX Highlights Pioneering Research Indicating a Role for..
23/8/202414:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202413:00GLOBEXORTX Announces Filing and Mailing of the Meeting Documents..
22/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202421:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202413:00GLOBEXORTX Announces Presentation at American Society of..
12/7/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
Apertura: Min: Max:
Chiusura: 0,95

La tua Cronologia

NASDAQ
XRTX
XORTX Therapeutics
BIT
UC8T3P
Unicredit Bank
BIT
UC8XVY
Unicredit Bank
BIT
EXEC
Execus
BIT
JPCT
JPMorgan ETFs IE ICAV Ca...
TG
JMX
MaxLinear
BIT
UC46D4
Unicredit Bank
BIT
UC3K2F
Unicredit Bank
BIT
P1RLI5
BNP Paribas Issuance
BIT
1MPC
Marathon Petro
AQSE
VUAG.GB
Vanguard Funds
BIT
P1RKH9
BNP Paribas Issuance
LSE
FRR
Frontera
ASX
RMX
Red Mountain Mining
AQSE
STB.GB
SECURE TRUST BANK
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci